VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

ACTRIMS 2022 | The potential of non-invasive brain stimulating therapies in negating the adverse symptoms of MS

Leigh Charvet, PhD, New York University Grossman School of Medicine, New York, NY, outlines the potential of non-invasive brain stimulation therapies in reducing the adverse symptoms of negated cognitive and motor function in multiple sclerosis (MS). Being a rapidly developing therapeutic area, transcranial direct current stimulation (tDCS) is the most studied of all existing techniques. Prof. Charvet discusses a study looking at pairing tDCS with motor training to strengthen training outcomes in patients with progressive MS and hand impairment. Researchers developed an extensive protocol of remotely supervised tDCS that delivers treatment in a home setting, underlining a significant advantage of not having to remain, or travel back and forth from a clinical environment. The rehabilitation setting is described as a means to pair the stimulation for functional targeting, with the region that is engaged in the training activity – reinforcing the learning to ensure a greater outcomes. This interview took place at the ACTRIMS Forum 2022 in West Palm Beach, Florida.


Prof. Charvet reports the following disclosures:
Funding: US Department of Defense & National Multiple Sclerosis Society